Acne

Published on 06/06/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1419 times

125 Acne

Acne vulgaris is the most common skin condition of teenagers, affecting up to 85% of adolescents and frequently continuing into adulthood. Increases in circulating hormones during puberty stimulate acne formation, which often occurs at a time of emotional insecurity. In addition to physical scarring, patients with severe acne can experience significant psychological morbidity. Pediatricians are often the first health care providers to care for patients with acne and have the opportunity to make a positive impact.

Etiology And Pathogenesis

An appreciation of the pathogenesis of acne facilitates a better understanding of targeted treatments. Acne develops in the pilosebaceous unit (Figure 125-1). There are four primary factors involved: abnormal keratinization, increased sebum production, proliferation of Propionibacterium acnes bacteria, and inflammation. With the onset of adrenarche, there is an increase in androgen production and a resultant increase in sebum secretion. Each sebaceous gland has a different threshold of androgen sensitivity, effecting an individually unique response to puberty. Simultaneously, there is increased proliferation of keratinocytes and decreased desquamation. The accumulation of sebum and keratinocytes leads to the formation of the microcomedo, the precursor to acne lesions. P. acnes, a normal skin inhabitant, thrives in this lipid-rich environment. The organisms release chemotactic factors, setting up an inflammatory response. Depending on the contribution of each primary factor, a microcomedo can evolve into a closed comedo (whitehead), open comedo (blackhead) (Figure 125-2), or an inflammatory pustule, papule, or nodule if the sebum, keratin, and microorganisms, with the accumulation of inflammatory cells, rupture into the dermis.

Extrinsic factors can exacerbate acne. Although many patients erroneously believe that acne is caused by not keeping the skin clean, cleansing the face helps clear the skin of surface lipids but does not help prevent acne. Furthermore, aggressive cleansing with washcloths or loofahs as well as manipulation and squeezing of lesions can aggravate them by provoking an inflammatory response and can also lead to scarring. Additionally, cosmetics, hair preparations, and occlusive clothing can all worsen facial and body acne. Stress can also lead to an increase in androgenic hormones and thus exacerbate acne.

There is little evidence to show that particular foods worsen acne. One study has shown an increased self-reported rate of acne during adolescence with consumption of milk. However, this relationship was thought to be secondary to acnegenic hormones and bioactive molecules in milk. Further study is needed in this area to prove or disprove any possible association.

Climate also seems to affect acne, with summer attenuating symptoms, yet this correlation is confounded by the fact that summertime generally harbors less stress, which has been associated with acne flares.

Clinical Presentation

Acne is a disease that can be seen in the first year of life, early childhood, the prepubertal period, and puberty. Neonatal cephalic pustulosis, formerly referred to as neonatal acne, appears in the first 3 months after birth and usually resolves in 1 to 3 months. In neonates, it is extremely important to exclude other bacterial, viral, or fungal causes, but a physician should also consider milia, erythema toxicum neonatorum, transient neonatal pustulosis, and sebaceous gland hyperplasia. Infantile or toddler acne is less common and usually presents between 3 and 6 months of life and can last 1 to 2 years. This is not typically associated with precocious puberty or a hormonal imbalance but needs to be considered in conjunction with a thorough history and physical examination. See Table 125-1 for a comparison of acne seen in neonates and toddlers. Acne can present in any location where there are sebaceous glands. In addition to the face, it is frequently found on the neck, upper chest, shoulders, and back (see Figure 125-2). There are multiple classification systems used to talk about acne, but a description of the lesions and their locations is most helpful. The resolution of acne may leave postinflammatory changes that usually resolve themselves but may take weeks to months, especially in darker pigmented patients. Moderate and severe acne can leave permanent scars.

The diagnosis of acne is relatively straightforward. Typical acne includes comedones, papules, pustules, and nodules in the distribution of the face, upper back, and chest. Acne that begins at an abnormal age, particularly severe acne, acne accompanied by an abnormal growth history or virilization, or acne that is recalcitrant to treatment, should be further evaluated. The physician may want to consider an underlying disorder, such as premature adrenarche, precocious puberty, Cushing’s syndrome, congenital adrenal hyperplasia, and gonadal or adrenal tumors, or an alternative diagnosis if the lesions are not typical (Box 125-1). Perioral dermatitis and facial angiofibromas are shown in Figure 125-3.

Management

The initial evaluation of a patient with acne begins with a complete history. Most patients have no relevant history of systemic disease, but particular attention must be paid to a history or physical examination that is consistent with signs of endocrine dysfunction in patients with an atypical age of presentation and lesion morphology. Hyperandrogenism can cause abnormal weight gain, menstrual irregularities, hirsutism, and signs of insulin resistance such as acanthosis nigricans. Elevated cortisol levels can cause hypertension, striae, or a buffalo hump. Signs of virilization such as decreased breast size, alopecia, and clitoromegaly can be attributable to an underlying adrenal or ovarian tumor. In addition, acne-associated spondyloarthropathies have been associated with severe acne, including acne fulminans, PAPA (pyogenic arthritis, pyoderma gangrenosum, and acne), and SAPHO (synovitis, acne, pustulosis, hyperostosis, osteomyelitis) syndrome. A complete medication history must also be taken. The physical examination should focus on the type and location of the lesions, postinflammatory changes, and scarring. In cases with red flags for an underlying systemic disease, laboratory evaluation may include measuring levels of free and total testosterone, DHEA-S (dehydroepiandrosterone sulfate), follicle-stimulating hormone, luteinizing hormone, 17 α-hydroxyprogesterone, and prolactin. Some experts also recommend an adrenocorticotropic hormone (ACTH) stimulation test. Bone age is a useful radiologic study for hyperandrogenism. A referral to an endocrinologist is also appropriate.

Treatment of acne should begin with good skin hygiene. Patients should be instructed to use nonirritating, noncomedogenic cleansers, which should be applied gently without scrubbing or using any harsh washing materials, as well as noncomedogenic moisturizers and sunscreen. Patients should be counseled that acne takes weeks to clear, and close follow-up should be arranged to assess the efficacy of treatment, side effects, and barriers to compliance. Often, teenagers will give up too early on therapy that would have been successful if they had been counseled that it will take weeks for full effect.

In general, when choosing a topical treatment, the vehicle should complement the patient’s skin type and be realistic for its distribution of placement. For example, whereas gels may provide some drying action, creams are less likely to dry but more likely to leave a white film in dark-skinned patients.

See Figure 125-4 for an acne treatment algorithm for the initial management strategies for the treatment of acne.

Topical Retinoids

Topical retinoids are considered the foundation of maintenance and treatment therapy of both comedonal and inflammatory acne. They help regulate keratinocyte desquamation and have a direct antiinflammatory effect, preventing microcomedone formation and allowing greater access for topical antibiotic treatment, if being used.

This treatment should be used at the onset of therapy and applied to all affected areas. Topical retinoids can cause irritation, erythema, burning, and pruritus, so it is recommended to start with reduced frequency of application for improved compliance. A pea-sized amount allocated into four equal parts is sufficient to cover the entire face.

Caution should be taken when adding multiple therapies at the same time because they can all be drying. It is generally better to start with a lower strength formulation and increase it as needed. Cream formulations of retinoids are less potent but also less irritating than their gel counterparts. See Table 125-2 for examples of topical retinoids available in the United States.

Table 125-2 Topical Retinoids

Retinoids Comments Side Effects
Tretinoin (available in cream, gel, solution, microsphere gel) Tretinoin is affected by light and degrades to a greater extent when used together with benzoyl peroxide. Irritation, erythema, burning, pruritus
Adapalene (available in gel or cream) Well tolerated at its lowest concentration but can be less effective.
May be used concomitantly with benzoyl peroxide
Tazarotene (available in gel or cream) More irritating but effective at comedolysis.
Tazarotene is contraindicated during pregnancy.

Systemic Antibiotics and Other Systemic Therapies

Oral antibiotics should be used for the treatment of moderate to severe acne or widespread involvement of the trunk. Although maintaining retinoid therapy is important for the prevention of acne, as already mentioned, treatment with oral antibiotics should be discontinued after a taper with the resolution of inflammatory lesions (Table 125-3).

Table 125-3 Systemic Therapies for Acne

Medication Comments Some Notable Side Effects
Erythromycin Useful in younger patients who have contraindications to tetracycline use GI upset, drug interactions
Tetracycline Avoid in children younger than 8 years of age and pregnant women because of permanent discoloration of the teeth and abnormal skeletal development
Should not be taken with calcium-based foods or medications because they will decrease absorption
GI upset, photosensitivity, tooth discoloration
Doxycycline   Phototoxicity, GI upset
Minocycline Pseudotumor cerebri, vertigo, SLE-like reaction, systemic hypersensitivity and Stevens-Johnson syndrome, and autoimmune hepatitis
Oral contraceptives containing estrogen Ortho Tri-Cyclen, Estrostep, and Yaz are approved by the FDA for acne Increased risk of thromboembolism, weight changes, mood changes
Spironolactone   Menstrual irregularities
Isotretinoin Possible correlation with isotretinoin and depression has been made; the FDA has implemented iPLEDGE, a program that monitors all patients who are prescribed isotretinoin Teratogenicity, hypertriglyceridemia, leukopenia, and elevated liver function test results; more commonly, patients develop dry skin, eyes, and mucosa

FDA, Food and Drug Administration; GI, gastrointestinal SLE, systemic lupus erythematous.

Oral contraceptives containing estrogen, spironolactone, an androgen antagonist, and isotretinoin are therapies for patients who have severe acne and have not responded to first-line therapy. Of note, certain forms of contraception, such as Depo-Provera shots, have been shown to worsen acne. Isotretinoin, a vitamin A derivative, is best suited for nodulocystic acne. It is extremely successful and may provide more long-lasting benefits than other acne therapies.